NLRP3 and juvenile Huntington disease: R6/2 mice (transgenic mice of Huntington’s disease) with Gal3 gene mutation in the striatum reduced the number of mHTT and inhibited NLRP3 inflammasome activation in the microglia, mitigating the effects of neuronal damage [97,102].